SelenBio

SelenBio

Early Stage

antibacterial technology for a wide variety of use cases

antibacterial technology for a wide variety of use cases

Overview

Raised this Round: Raised: $147,972

Total Commitments ($USD)

Platform

Netcapital

Start Date

10/02/2019

Close Date

04/28/2020

Min. Goal
$10,000
Max. Goal
$1,070,000
Min. Investment

$4

Security Type

Equity - Common

Series

Seed

SEC Filing Type

RegCF    Open SEC Filing

Price Per Share

$4.00

Pre-Money Valuation

$19,621,196

Year Founded

2017

Industry

Healthcare & Pharmaceuticals

Tech Sector

Biotech

Distribution Model

B2B

Margin

High

Capital Intensity

High

Location

Austin, California

Business Type

High Growth

SelenBio, a biotechnology company with a post-money valuation of $20.7 million, is raising funds on NetCapital. The company develops an antibacterial technology that prevents the formation of biofilm in dental, medical, industrial, and consumer applications. SelenBio uses a unique selenium-based compound, SELDOX, to keep the applications infection-free. The company was founded by Kenny Gallagher and Karl Doenges. The proceeds of the current crowdfunding round, with a minimum target of $10,000 and a maximum target of $1,070,000, will be used for research & development, operations, completion of current projects, sales & marketing, and compensation for managers. SelenBio is working on multiple projects with excellent traction and has already received the FDA approval for SELDOX.

Summary Profit and Loss Statement

Most Recent Year Prior Year

Revenue

$12,142

$1,039

COGS

$11,785

$871

Tax

$0

$0

 

 

Net Income

$-453,939

$-134,867

Summary Balance Sheet

Most Recent Year Prior Year

Cash

$550,794

$104,479

Accounts Receivable

$153

$213

Total Assets

$1,044,713

$475,538

Short-Term Debt

$0

$0

Long-Term Debt

$0

$0

Total Liabilities

$0

$0

Financials as of: 10/02/2019
Create a free account today to gain access to KingsCrowd analytics.

Upgrade to gain access

Pay Monthly
Annually (Save 17%)

Edge

$25 /month
billed annually
Free portfolio tracking, data-driven ratings, AI analysis and reports
Plan Includes:
Everything in Free, plus
Company specific KingsCrowd ratings and analyst reports
Deal explorer and side-by-side comparison
Startup exit and failure tracking
Startup market filters and historical industry data
Advanced company search ( with ratings)
Get Edge Annual
Already a member? Log in here.
Founders: enhance your startup's credibility on KingsCrowd. Create an account to claim this raise page.
Add to portfolio
SelenBio on Netcapital
Platform: Netcapital
Security Type: Equity - Common
Valuation: $19,621,196
Price per Share: $4.00

Follow company

Follow SelenBio on Netcapital

Buy SelenBio's Deal Report

Warning: according to the close date for this deal, SelenBio may no longer be accepting investments.

SelenBio Deal Report

Get KingsCrowd’s comprehensive report on SelenBio including:

  • How our proprietary algorithm rates their current capital raise (1-5 stars)
  • Detailed price, market, team, differentiators, performance, and risk ratings
  • Whether SelenBio is undervalued or overvalued
  • Scores on the founding team and key personnel's background and expertise

Buy the SelenBio deal report for only $10!

Email address:
Looking to buy more than one deal report? Get unlimited reports by upgrading to Edge